meta-analysis | Q815382 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(09)60552-3 |
P698 | PubMed publication ID | 19303634 |
P50 | author | Patrick W Serruys | Q63253317 |
Christian W Hamm | Q66829316 | ||
Didier Carrie | Q68077344 | ||
Douglas K Owens | Q98149051 | ||
Rodney Stables | Q38590246 | ||
Maria M. Brooks | Q41533938 | ||
Sheryl F. Kelsey | Q42124184 | ||
Mark A. Hlatky | Q56166694 | ||
Kathryn M. McDonald | Q59748119 | ||
P2093 | author name string | Alfredo Rodriguez | |
Marcus Flather | |||
Eric Boersma | |||
Nicolas Danchin | |||
Stuart J Pocock | |||
Dena M Bravata | |||
Neuza Lopes | |||
Spencer B King | |||
Tim C Clayton | |||
Jean Booth | |||
Derek B Boothroyd | |||
Andrzej S Kosinski | |||
Ulrich Sigwart | |||
Whady A Hueb | |||
Jan Kähler | |||
P2860 | cites work | Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI) | Q71020149 |
A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes | Q73298948 | ||
Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group | Q73661215 | ||
Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode | Q73762947 | ||
Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty | Q73841644 | ||
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina | Q77530104 | ||
The final 10-year follow-up results from the BARI randomized trial | Q80157921 | ||
Selection of surgical or percutaneous coronary intervention provides differential longevity benefit | Q80333603 | ||
13-year follow-up of the German angioplasty bypass surgery investigation | Q81884927 | ||
Evidence for use of coronary stents. A hierarchical bayesian meta-analysis | Q28205005 | ||
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators | Q28281001 | ||
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group | Q30596519 | ||
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. | Q31016826 | ||
Meta-analysis of the literature or of individual patient data: is there a difference? | Q34334544 | ||
Long-term outcomes of coronary-artery bypass grafting versus stent implantation | Q34421559 | ||
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial | Q34740055 | ||
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease | Q34948400 | ||
Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? | Q36017145 | ||
Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group | Q36790212 | ||
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. | Q36972301 | ||
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery | Q39361157 | ||
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty | Q39484680 | ||
Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Depart | Q43408475 | ||
A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents | Q45019905 | ||
The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. | Q45230904 | ||
Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST) | Q50658760 | ||
Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. | Q51055015 | ||
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. | Q51179164 | ||
Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). | Q51372326 | ||
Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. | Q51372330 | ||
Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. | Q51681449 | ||
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients | Q54066813 | ||
Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease | Q57589046 | ||
P433 | issue | 9670 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
coronary artery bypass surgery | Q186020 | ||
cardiac surgery | Q235007 | ||
collaboration | Q1145523 | ||
data collaboration | Q96060107 | ||
P304 | page(s) | 1190-1197 | |
P577 | publication date | 2009-03-19 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials | |
P478 | volume | 373 |
Q56770452 | Q56770452 |
Q37953885 | 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi |
Q44633782 | 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps |
Q22241922 | 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines |
Q30653434 | A systematic review of individual patient data meta-analyses on surgical interventions |
Q37131837 | A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials |
Q33647497 | ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy |
Q37626030 | Adoption and effectiveness of internal mammary artery grafting in coronary artery bypass surgery among Medicare beneficiaries. |
Q46231868 | Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. |
Q38177869 | Angina pectoris: current therapy and future treatment options |
Q37607416 | Assessment of a method to detect signals for updating systematic reviews |
Q36402889 | Association of Angiotensin-Converting Enzyme Genotype, Insertion/Deletion Polymorphism and Saphenous Vein Graft Atherosclerosis in Iranian Patients |
Q84544342 | Best way to revascularize patients with main stem and three vessel lesions: patients should undergo PCI! |
Q49555606 | Bilateral Versus Single Internal Thoracic Artery Grafts. |
Q46098036 | Biophysical Cueing and Vascular Endothelial Cell Behavior. |
Q37659163 | CABG in 2012: Evidence, practice and the evolution of guidelines |
Q45063559 | CABG or PCI for revascularisation in patients with diabetes? |
Q84135615 | CABG versus PCI for multivessel coronary artery disease |
Q35530702 | Cardiac rehabilitation versus standard care after aortic aneurysm repair (Aneurysm CaRe): study protocol for a randomised controlled trial |
Q44939466 | Cardiovascular disease: Is CABG really better than PCI in dialysis patients? |
Q36295813 | Case 5/2015 - 88-Year-Old Female with Chronic Coronary Artery Disease, Upper Limb Thrombosis, Atrial Fibrillation and Cardiac Arrest |
Q35778266 | Changes in the Practice of Coronary Revascularization between 2006 and 2010 in the Republic of Korea |
Q42322686 | Changes in the safety paradigm with percutaneous coronary interventions in the modern era: Lessons learned from the ASCERT registry |
Q30492121 | Chronic coronary artery disease: diagnosis and management |
Q37647406 | Clinical Outcomes in Diabetic Patients Who Underwent Percutaneous Coronary Intervention during the Plain Old Balloon Angioplasty (POBA)-, Bare Metal Stents (BMS)- and Drug-eluting Stents (DES)-eras from 1984 to 2010. |
Q41112088 | Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG? |
Q38071219 | Clinical evidence versus patients' perception of coronary revascularization |
Q38162889 | Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation |
Q34017377 | Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease. |
Q33983793 | Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study |
Q36351313 | Comparative effectiveness of revascularization strategies |
Q38153783 | Comparative effectiveness of revascularization strategies in stable ischemic heart disease: current perspective and literature review |
Q41414051 | Comparing hospital performance within and across countries: an illustrative study of coronary artery bypass graft surgery in England and Spain. |
Q26766572 | Comparing the Clinical Outcomes Between Insulin-treated and Non-insulin-treated Patients With Type 2 Diabetes Mellitus After Coronary Artery Bypass Surgery: A Systematic Review and Meta-analysis |
Q38195447 | Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials |
Q35434402 | Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials |
Q33924170 | Composite outcomes in coronary bypass surgery versus percutaneous intervention |
Q40202463 | Conditions for confounding of interactions |
Q26864819 | Conduits for coronary bypass: strategies |
Q92899254 | Coronary Artery Bypass Graft Surgery Improves Survival Without Increasing the Risk of Stroke in Patients with Ischemic Heart Failure in Comparison to Percutaneous Coronary Intervention: A Meta-Analysis With 54,173 Patients |
Q33740804 | Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease |
Q38896783 | Coronary Stents in Diabetic Patients: State of the Knowledge |
Q34052895 | Coronary artery bypass graft type and outcomes in maintenance dialysis |
Q38217328 | Coronary artery bypass grafting versus drug-eluting stents in patients with severe coronary artery disease and diabetes mellitus: systematic review and meta-analysis |
Q26830855 | Coronary artery bypass grafting: Part 1--the evolution over the first 50 years |
Q36355228 | Coronary artery disease and diabetes mellitus |
Q35193488 | Coronary artery disease in type 2 diabetes mellitus: Recent treatment strategies and future perspectives |
Q83904156 | Coronary artery disease: Risk models for revascularization--the search continues |
Q44063681 | Coronary artery disease: revascularization strategies for patients with CAD and diabetes |
Q51034959 | Coronary bypass surgery versus percutaneous coronary intervention: cost-effectiveness in Iran: a study in patients with multivessel coronary artery disease. |
Q34312812 | Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis |
Q36801055 | Coronary intervention in diabetes: is it different |
Q83694476 | Coronary revascularization in diabetic patients. A focus on the 3-year SYNTAX trial outcomes |
Q34789840 | Coronary revascularization in diabetic patients: Current state of evidence. |
Q26778104 | Coronary revascularization in the elderly with stable angina |
Q89612564 | Current Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Intervention |
Q37926750 | Current concepts on coronary revascularization in diabetic patients |
Q37663898 | Current options for treatment of chronic coronary artery disease |
Q83694813 | Debate over patient-centered care: percutaneous coronary intervention or coronary artery bypass grafting? |
Q35957953 | Demographic and Socioeconomic Factors of Patients With Coronary Artery Diseases Undertreatment of Coronary Artery Bypass Grafting, Percutaneous Coronary Intervention and Drug Therapy in Mashhad, Iran |
Q35739868 | Determinants of variations in coronary revascularization practices |
Q33647298 | Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society. |
Q42332217 | Diabetes mellitus and multivessel coronary artery disease: an ongoing battle for an ideal treatment strategy |
Q38018724 | Diabetes mellitus and the heart |
Q45781910 | Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry |
Q41889254 | Drug-eluting stents in multivessel coronary artery disease: cost effectiveness and clinical outcomes |
Q22241786 | ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary |
Q36913808 | Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator |
Q89876090 | Economic Analysis of Surgical and Interventional Treatments for Patients with Complex Coronary Artery Disease: Insights from a One-Year Single-Center Study |
Q45301806 | Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial |
Q48002756 | Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions |
Q30660247 | Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data |
Q28548148 | Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials |
Q34999733 | Efficient gene transfer and durable transgene expression in grafted rabbit veins |
Q37588002 | Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era. |
Q36248124 | Executive Summary of the Guidelines on Stable Coronary Disease |
Q36746495 | Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial |
Q28079800 | Has the difference in mortality between percutaneous coronary intervention and coronary artery bypass grafting in people with heart disease and diabetes changed over the years? A systematic review and meta-regression |
Q39752158 | Hospital Surgical Volumes and Mortality after Coronary Artery Bypass Grafting: Using International Comparisons to Determine a Safe Threshold. |
Q38031999 | How to generalize efficacy results of randomized trials: recommendations based on a systematic review of possible approaches |
Q34925593 | Immediate Postoperative Complications in Patients Undergoing CABG; Investigating the Role of Prior Coronary Stenting |
Q34719102 | Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention. |
Q36353650 | Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials |
Q44337285 | In vivo study of a model tissue-engineered small-diameter vascular bypass graft |
Q51157089 | In vivo study of alginate hydrogel conglutinating cells to polycaprolactone vascular scaffolds fabricated by electrospinning. |
Q36533510 | Incomplete revascularization in the drug eluting stent era permits meaningful long-term (12-78 months) outcomes in patients ≥ 75 years with acute coronary syndrome |
Q21559668 | Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? |
Q38777054 | Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting†. |
Q37633665 | Inhibition of vein graft stenosis with a c-jun targeting DNAzyme in a cationic liposomal formulation containing 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). |
Q27013126 | Is the advantage of coronary bypass graft surgery over percutaneous coronary intervention in diabetic patients with severe multivessel disease influenced by the status of insulin requirement? |
Q38689158 | Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation |
Q36836240 | Long-Term Risk of Stroke in Patients With Type 1 and Type 2 Diabetes Following Coronary Artery Bypass Grafting |
Q36658583 | Long-term Outcome after Percutaneous Coronary Intervention Compared with Minimally Invasive Coronary Artery Bypass Surgery in the Elderly |
Q47687627 | Long-term clinical outcomes, health-related quality of life, and costs in different treatment modalities of stable coronary artery disease |
Q34427865 | Long-term mortality in minimally invasive compared with sternotomy coronary artery bypass surgery in the geriatric population (75 years and older patients). |
Q35734651 | Long-term mortality of coronary artery bypass grafting and bare-metal stenting |
Q37390057 | Long-term survival after coronary bypass surgery and percutaneous coronary intervention |
Q30248679 | Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: Meta-analysis of randomized controlled trials |
Q39913995 | Major themes for 2009 in cardiothoracic and vascular anesthesia |
Q38106502 | Management of the patient with diabetes and coronary artery disease: a contemporary review |
Q30239853 | Management standards for stable coronary artery disease in India |
Q43705921 | Medical therapy v. PCI in stable coronary artery disease: a cost-effectiveness analysis |
Q26829693 | Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes |
Q41500175 | Morphology of Coronary Ostia in Domestic Shorthair Cat. |
Q52373206 | Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. |
Q36426128 | Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. |
Q46167057 | Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus |
Q38124877 | Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice |
Q37277273 | Multivessel coronary revascularization and outcomes in kidney transplant recipients |
Q82433396 | Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry |
Q36087918 | Myocardial revascularization for the elderly: current options, role of off-pump coronary artery bypass grafting and outcomes |
Q87615885 | Neurological complications of cardiac surgery |
Q37111596 | New frontiers in cardiovascular behavioral medicine: comparative effectiveness of exercise and medication in treating depression |
Q48194887 | Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6‑month vs. 12‑month dual-antiplatelet therapy (DAPT). |
Q37887771 | Nitric oxide: a guardian for vascular grafts? |
Q34281305 | Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized controlled trials. |
Q39410697 | Optimal choice of coronary revascularization and stent type in diabetic patients with coronary artery disease |
Q38138348 | Optimal revascularization for complex coronary artery disease |
Q38679722 | Optimal use of arterial grafts during current coronary artery bypass surgery |
Q47134510 | Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus |
Q37066652 | Outcomes of DES in Diabetic and Nondiabetic Patients with Complex Coronary Artery Disease after Risk Stratification by the SYNTAX Score |
Q85646078 | Overview: Japanese guidelines for myocardial revascularization to treat stable ischemic heart disease 2012 |
Q83514069 | PCI or CABG in coronary artery disease? |
Q38225459 | Percutaneous coronary intervention compared with coronary artery bypass graft in coronary artery disease patients with chronic kidney disease: a systematic review and meta-analysis |
Q91605679 | Percutaneous coronary intervention in diabetic versus non-diabetic patients with prior coronary artery bypass grafting: a propensity score matching study |
Q82791112 | Percutaneous coronary intervention in the elderly |
Q37561885 | Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome |
Q26471346 | Percutaneous coronary intervention versus coronary artery bypass grafting for adults with diabetes and multivessel coronary disease |
Q84471489 | Percutaneous coronary interventions for all patients with complex coronary artery disease: triple vessel disease or left main coronary artery disease. Yes? No? Don't know? |
Q38071968 | Perioperative control of blood glucose level in cardiac surgery |
Q34497302 | Postoperative Staphylococcus aureus infections in Medicare beneficiaries |
Q36896610 | Practice Variation Among Hospitals in Revascularization Therapy and Its Association With Procedure-related Mortality |
Q44005280 | Prevalence and procedural outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with diabetes and multivessel coronary artery disease |
Q28070388 | Psychosocial Factors in Diabetes and Cardiovascular Risk |
Q46456558 | Randomized trials of PCIs versus CABG surgery: why coronary stenting should remain the first choice of revascularization in non-diabetic patients and why the controversy is still present in diabetics |
Q45954313 | Rationality and the generalization of randomized controlled trial evidence. |
Q38875527 | Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome. |
Q38735428 | Revascularization for Advanced Coronary Artery Disease in Type 2 Diabetic Patients: Choosing Wisely Between PCI and Surgery |
Q34793647 | Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting |
Q38013670 | Revascularization for left main and multivessel coronary artery disease in the drug-eluting stent era: integration of recent drug-eluting stent trials |
Q38779868 | Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization |
Q38353639 | Revascularization in patients with diabetes: PCI or CABG or none at all. |
Q35739893 | Revascularization options: one size does not fit all. |
Q37827869 | Revascularization treatment of stable coronary artery disease |
Q30815345 | Reviews of individual patient data (IPD) are useful for geriatrics: an overview of available IPD reviews |
Q36092782 | Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus |
Q53655124 | SYNTAX-justified trend toward restricting coronary artery bypass grafting to more serious cases. |
Q34224601 | Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association |
Q84850268 | Secondary prevention of ischaemic cardiac events |
Q37407828 | Severe ischemic cardiomyopathy-a new answer in management? |
Q42126164 | Short, Intermediate and long term outcomes of CABG vs. PCI with DES in Patients With Multivessel Coronary Artery Disease. Meta-Analysis of Six Randomized Controlled Trials |
Q35619894 | Significance of off-pump coronary artery bypass grafting compared with percutaneous coronary intervention: a propensity score analysis |
Q38579536 | Stable coronary artery disease: revascularisation and invasive strategies |
Q64970571 | Stent versus Coronary Artery Bypass Surgery in Multi-Vessel and Left Main Coronary Artery Disease: A Meta-Analysis of Randomized Trials with Subgroups Evaluation. |
Q42552195 | Stents or surgery in coronary artery disease in 2013. |
Q87976847 | Strategies for multivessel revascularization in patients with diabetes: the FREEDOM trial |
Q34771915 | Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention |
Q38262668 | Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease |
Q40849348 | The SYNTAX score is correlated with long-term outcomes of coronary artery bypass grafting for complex coronary artery lesions |
Q35190270 | The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes). |
Q37725477 | The evolution of cardiovascular surgery in elderly patient: a review of current options and outcomes |
Q41076426 | The impact of type 2 diabetes mellitus on prognosis in patients with non-ST elevation myocardial infarction. |
Q42613034 | The potential of cellular technology to mediate social networks for support of chronic disease self-management |
Q36982530 | The role of CABG in the era of drug-eluting stents: a surgeon's viewpoint |
Q37306857 | The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus |
Q84121722 | The role of revascularization versus medical therapy in patients with type 2 diabetes mellitus and coronary artery disease |
Q41870519 | The use of modern interventional cardiology tools to verify lesion significance and optimize procedural outcome in a diabetic patient with multivessel disease |
Q24289039 | Three simple rules to ensure reasonably credible subgroup analyses |
Q38049323 | Total arterial coronary artery bypass grafting in patients with diabetes: an 8-year experience |
Q28539350 | Treatment for stable coronary artery disease: a network meta-analysis of cost-effectiveness studies |
Q58009187 | Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial† |
Q33971106 | Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. |
Q38152246 | Trialogue Plus: Management of cardiovascular risk in hyperglycaemic/diabetic patients at hospital discharge |
Q38558645 | Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey |
Q37644740 | Unprotected left main percutaneous coronary intervention in a 108-year-old patient |
Q58592681 | Up to 15-Year Survival of Men and Women after Percutaneous Coronary Intervention Paid by the Brazilian Public Healthcare System in the State of Rio de Janeiro, 1999-2010 |
Q36327454 | Will comparative effectiveness research finally succeed? |
Q89447942 | [Cardiac surgery in the elderly] |
Q53737554 | [Comments on the 2013 ESC/EASD guidelines on diabetes, prediabetes and cardiovascular diseases]. |
Q82239222 | [Modern coronary surgery, the SYNTAX trial and updated guidelines] |
Q51359252 | [Prevalence of undetected diabetes mellitus in invasive and interventional cardiology. Silent diabetes in the catheterization laboratory]. |
Q22242895 | ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el |
Search more.